Intelligience executed an 'Indication Prioritization' assignment to identify the top indications for the Client. The study was based on determining the 'Unmet Medical Need' for each indication.
Intelligience undertook a detailed innovation landscape study on 'Wearable Medical Devices' to identify innovative solutions in the domain.
The study was aimed at identifying the key aspects of clinical and competitive scenario along with business strategies of key market leaders.
The study was aimed at identifying competitive threats for the Client based on a thorough assessment of secondary and primary research data.
The study was aimed at understanding the current state of innovation protection in the domain of CD19 CARs.